B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Feprazone

63 PubMed studies analyzed ยท 8 RCTs ยท Evidence Score: 41.9

Research Domains

Feprazone has been studied across 17 research domains including ๐Ÿ”ฌ Inflammation, ๐Ÿฆด Bone & Joint, ๐Ÿ’Š Pain, ๐Ÿซ Respiratory, ๐Ÿซ Liver & Detox. The primary research focus is ๐Ÿ”ฌ Inflammation with 37% of studies addressing this area.

Loading evidence profile...

This evidence profile for Feprazone is generated deterministically from 63 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.